Neuropharmaceutics

A drug used to treat neuropsychiatric, neuropsychological, or nervous-system disorders (as depression, obesity, schizophrenia, or Alzheimer's disease). Neuro-pharmaceutics focuses on identification of therapeutic targets, and then translating those discoveries into drug and therapy development. Research in neuropharmaceutics includes: drug discovery for limiting high frequency activity in epilepsy; drug transport proteins that control drug distribution to target tissues; spinal delivery of analgesics to chronic pain treatment; drugs for the treatment of depression, bipolar disorder, and schizophrenia; intranasal delivery methods for the treatment of Alzheimer’s disease; development of strategies to evaluate therapeutics on preclinical models of Alzheimer’s and Parkinson’s disease; anti-atherogenic and anti-diabetic therapies for the prevention and treatment of AD and other age-related dementias; and development of analgesic agents for chronic pain.

 

  • Drug discovery
  • Neuropharmacological mechanisms
  • Neuroprotective measures
  • Neuroendocrine Regulation
  • Neurophysiological regulations mechanisms

Related Conference of Neuropharmaceutics

Neuropharmaceutics Conference Speakers